Design and synthesis of novel 1,3,5-triphenyl pyrazolines as potential anti-inflammatory agents through allosteric inhibition of protein kinase Czeta (PKCζ).

No abstract is available for this paper.

• Publication year

  2018

• Venue

  MedChemComm

• Publication date

  2018-06-20

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/c8md00100fPMID 30108997PMCID PMC6072096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological inhibition of protein kinase C (PKC)ζ downregulates the expression of cytokines involved in the pathogenesis of chronic obstructive pulmonary disease (COPD).

  2016cited by this paper
• Elevated Exhaled Nitric Oxide in Allergen-Provoked Asthma Is Associated with Airway Epithelial iNOS

  2014cited by this paper
• Discovery and optimization of 1,3,5-trisubstituted pyrazolines as potent and highly selective allosteric inhibitors of protein kinase C-ζ.

  2014cited by this paper
• Targeting proteasomal pathways by dietary curcumin for cancer prevention and treatment.

  2014cited by this paper
• The atypical PKCs in inflammation: NF‐κB and beyond

  2012cited by this paper
• Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.

  2012cited by this paper
• Bronchial inflammation induced PKCζ over-expression: involvement in mechanical properties of airway smooth muscle.

  2012cited by this paper
• New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitors.

  2012cited by this paper
• Nitric Oxide in Asthma Physiopathology

  2011cited by this paper
• 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCζ.

  2011cited by this paper
• Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model.

  2011cited by this paper
• Non-additivity of functional group contributions in protein-ligand binding: a comprehensive study by crystallography and isothermal titration calorimetry.

  2010cited by this paper
• Protein kinase C: poised to signal.

  2010cited by this paper
• Requirement for Inducible Nitric Oxide Synthase in Chronic Allergen Exposure-Induced Pulmonary Fibrosis but Not Inflammation

  2010cited by this paper
• Protein Kinase C Mediates Cigarette Smoke/Aldehyde- and Lipopolysaccharide-induced Lung Inflammation and Histone Modifications*

  2010cited by this paper
• 2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: design and synthesis of a potent and isoform selective PKC-zeta inhibitor.

  2009cited by this paper
• An Atypical Protein Kinase C (PKCζ) Plays a Critical Role in Lipopolysaccharide-Activated NF-κB in Human Peripheral Blood Monocytes and Macrophages1

  2009cited by this paper
• Crucial implication of protein kinase C (PKC)‐δ, PKC‐ζ, ERK‐1/2, and p38 MAPK in migration of human asthmatic eosinophils

  2009cited by this paper
• Therapeutic target validation of protein kinase C(PKC)-zeta for asthma using a mouse model.

  2009cited by this paper
• Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1.

  2009cited by this paper
• 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.

  2009cited by this paper
• Structural basis of protein kinase C isoform function.

  2008cited by this paper
• Nitric oxide, chronic inflammation and autoimmunity.

  2007cited by this paper
• PKCζ at the crossroad of NF-κB and Jak1/Stat6 signaling pathways

  2006cited by this paper
• The regulation of allergy and asthma

  2006cited by this paper
• Allosteric activation of the protein kinase PDK1 with low molecular weight compounds

  2006cited by this paper
• PKCzeta at the crossroad of NF-kappaB and Jak1/Stat6 signaling pathways.

  2006cited by this paper
• Control of T helper 2 cell function and allergic airway inflammation by PKCzeta.

  2005cited by this paper
• Crosstalk between PKCζ and the IL4/Stat6 pathway during T‐cell‐mediated hepatitis

  2004cited by this paper
• Asthma: an epidemic of dysregulated immunity

  2002cited by this paper
• Targeted Disruption of the ζPKC Gene Results in the Impairment of the NF-κB Pathway

  2001cited by this paper
• Targeted disruption of the zetaPKC gene results in the impairment of the NF-kappaB pathway.

  2001cited by this paper
• The atypical protein kinase Cs

  2000cited by this paper
• Multiple NF-κB Enhancer Elements Regulate Cytokine Induction of the Human Inducible Nitric Oxide Synthase Gene*

  1998cited by this paper
• Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes

  1996cited by this paper
• Transcriptional regulation of iNOS by IL-1 beta in cultured rat pulmonary artery smooth muscle cells.

  1996cited by this paper
• Oxidative stress in neurodegenerative diseases.

  1996cited by this paper
• Mediation of inflammation by encephalitogenic cells: interferon gamma induction of nitric oxide synthase and cyclooxygenase 2.

  1995cited by this paper
• PKC zeta is a molecular switch in signal transduction of TNF‐alpha, bifunctionally regulated by ceramide and arachidonic acid.

  1995cited by this paper
• The Cytokine Responsive Vascular Smooth Muscle Cell Enhancer of Inducible Nitric Oxide Synthase

  1995cited by this paper
• Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.

  1994cited by this paper

• Recent advances in PKC inhibitor development: Structural design strategies and therapeutic applications.

  2025cites this paper
• Discovery of 1,3-disubstituted prop-2-en-1-one derivatives as inhibitors of neutrophilic inflammation via modulation of MAPK and Akt pathways

  2024cites this paper
• Allosteric Regulation of Protein Kinases Downstream of PI3-Kinase Signalling.

  2019cites this paper